Envoy Medical, Inc. Class A

Stage 3 · Topping · week 3

As of Oct 22, 2026, Envoy Medical is in Stage 3, the topping phase, now in week 3 (since Oct 2, 2026). It closed at $0.60, 33.9% below its 52-week high and below its 200-day average, which is falling.

Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. More about the company

$0.60

-7.90% today

$46.0M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Topping: the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is COCH early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S4 16w

S4 27w

S4 32w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 6w → S3 1w → S4 16w → S1 4w → S4 2w → S1 8w → S2 4w → S3 5w → S4 9w → S1 10w → S4 27w → S1 12w → S4 32w → S1 9w → S4 7w → S1 6w → S2 6w → S3 3w current

Total tracked: 166 weeks across 18 stage runs.

COCH among Medical Devices72nd of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…72	COCHEnvoy Medical, Inc. Class A	Stage 3 · wk 3	33	−17.5%

vs 52W High

-33.9%

$0.39 lo$0.90 hi

33.9% below 52W high, weakening from peak

The stock is rolling over from its 52-week high. In Stage 3 distribution, new long positions carry high risk.

Stage Maturity

Week 3

1w13w26w

Week 3, early distribution

How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.

vs 200 DMA

-13.4%

200 DMA: $0.69 · sloping down

Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.

Rel Volume

2.66x

vs 50-day avg

Volume spikes on down days during Stage 3 signal distribution, with institutions exiting. Stage analysis reads that as a warning against new long positions.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-17.5%

-10.1%

-13.6%

YTD

-14.4%

-30.6%

Scan Membership

Breakout Watch

Latest: 2024-04-26

2 appearances in last 60 days. First seen: 2022-11-30.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S3

Wk 3 · Vol 2.66x

2026-10-21S3

Wk 3 · Vol 0.94x

2026-10-20S3

Wk 3 · Vol 1.99x

2026-10-19S3

Wk 3 · Vol 1.34x

2026-10-16S3

Wk 3 · Vol 0.53x

2026-10-15S3

Wk 2 · Vol 0.61x

2026-10-14S3

Wk 2 · Vol 1.32x

2026-10-13S3

Wk 2 · Vol 0.58x

2026-10-12S3

Wk 2 · Vol 1.73x

2026-10-09S3

Wk 2 · Vol 0.43x

2026-10-08S3

Wk 1 · Vol 0.35x

2026-10-07S3

Wk 1 · Vol 0.88x

Moving averages & range

50 DMA

$0.70

200 DMA

$0.69

52W High

$0.90

52W Low

$0.39

5D Low

$0.60

Resistance levels (recent highs)

20d High

$0.72

60d High

$0.80

120d High

$0.80

250d High

$0.90

Next resistance

+20.0%

to 20d High

Dividend Yield

0.00%

P/B 12.4

Envoy Medical: quick answers

What stage is Envoy Medical in?

As of Oct 22, 2026, Envoy Medical (COCH) is in Stage 3, the topping phase. It entered Stage 3 on Oct 2, 2026 and is in week 3. What the four stages mean

Is Envoy Medical in an uptrend?

Its uptrend has stalled. Envoy Medical is in Stage 3, the topping phase that follows an advance. It trades 13.4% below its 200-day average, which is falling.

How far is Envoy Medical from its 52-week high?

Envoy Medical closed at $0.60 on Oct 22, 2026, 33.9% below its 52-week high of $0.90. Its 52-week low is $0.39.

How has Envoy Medical performed over the past year?

As of Oct 22, 2026, Envoy Medical is down 30.6% over the past year and down 14.4% so far in 2026.

Which sector and industry is Envoy Medical in?

Envoy Medical is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.